Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dCELL Human Dermis
- Development stage
- Phase 4
- Lead developer
- Tissue Regenix
- Administration
- Topical
01
Overview
dCELL Human Dermis is an acellular dermal matrix (ADM) produced using the proprietary dCELL technology. This process involves the removal of cells, DNA, and other immunogenic components from human donor skin while preserving the structural integrity of the extracellular matrix (ECM), including collagen and elastin fibers. By maintaining the natural scaffold, the product provides a biocompatible environment that supports cellular infiltration, revascularization, and tissue remodeling. It is primarily indicated for the treatment of chronic and acute wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), as well as for use in plastic and reconstructive surgery. The developer, Tissue Regenix, utilizes this technology to minimize the risk of graft rejection while promoting effective wound healing.
- Brand names
- DermaPure
- Other names
- Decellularized human dermisdCELL dermisAcellular dermal matrix
Beyond the preview
Go deeper on dCELL Human Dermis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dCELL Human Dermis.